Oxymetazoline Nasal Spray Recalled Due to Manufacturing Process Deviation
Seaway Pharma is recalling oxymetazoline nasal spray due to manufacturing process deviations. No contamination was found in the final products.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II manufacturing recall with no actual product contamination found and no reported illnesses or injuries. The hazard is theoretical, based on a deviation in the water purification process that did not result in contaminated products.
Plain-English summary
Seaway Pharma Inc. is recalling oxymetazoline hydrochloride nasal spray (12-hour pump mist, 1 FL oz./30 mL bottles) sold under two brands: Quality Choice and Premier Value. The recall involves Lot # SD23032 with expiration date 04/30/2026, affecting approximately 7,992 bottles distributed in Michigan and Pennsylvania.
The recall was initiated due to a manufacturing process deviation. The firm reported possible microbial contamination in the purified water used in product manufacturing. Upon investigation, no contamination was detected in any of the final products. The U.S. Food and Drug Administration classified this as a Class II recall.
Consumers who possess affected product should not use it. The product may be returned to the place of purchase. Healthcare providers and patients with questions should contact the recalling firm or the FDA.
The recalled product
- Product
- OXYMETAZOLINE HYDROCHLORIDE (OXYMETAZOLINE HYDROCHLORIDE)
- Brand
- OXYMETAZOLINE HYDROCHLORIDE
- Manufacturer
- Seaway Pharma Inc.
- Category
- Drug — OTC Nasal Spray
- Hazard
- microbial-contamination
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # SD23032
- Exp 04/30/2026
UPCs (3)
- 0635515988446
- 635515988439
- 840986035098
Distribution
Distributed in 2 states:
- MI
- PA
Related recalls
Same brand · OXYMETAZOLINE HYDROCHLORIDE
- ModerateNasal Decongestant Recalled for Possible Manufacturing Water Contamination
FDA (Drugs) · 2024-01-10
- ModerateOTC Nasal Decongestant Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27